Lista de obras -

Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis

artículo científico publicado en 2014

Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer

artículo científico publicado en 2015

Circulating DNA and Survival in Solid Tumors

artículo científico publicado en 2015

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

artículo científico publicado en 2016

In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment.

artículo científico publicado en 2016

In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases.

artículo científico publicado en 2016

Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses

artículo científico publicado en 2015

Mapping Bromodomains in breast cancer and association with clinical outcome

scientific article published on 05 April 2019

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.

artículo científico publicado en 2017

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer

artículo científico publicado en 2020

Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors.

artículo científico publicado en 2015

Synthetic lethality interaction between Aurora kinases and CHEK1 inhibitors in ovarian cancer.

artículo científico

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors

artículo científico publicado en 2017

Transcriptome evolution from breast epithelial cells to basal-like tumors.

artículo científico publicado en 2017

Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer

artículo científico publicado en 2016

Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers.

artículo científico publicado en 2017

Lista de obras de

Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis

Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer

Circulating DNA and Survival in Solid Tumors

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment.

In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases.

Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses

Mapping Bromodomains in breast cancer and association with clinical outcome

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer

Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors.

Synthetic lethality interaction between Aurora kinases and CHEK1 inhibitors in ovarian cancer.

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors

Transcriptome evolution from breast epithelial cells to basal-like tumors.

Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer

Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers.